226 related articles for article (PubMed ID: 33843162)
41. Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable.
Ren J; Xu W; Su J; Ren X; Cheng D; Chen Z; Bender N; Mirshams M; Habbous S; de Almeida JR; Perez-Ordonez B; Goldstein DP; Wang JR; Bratman SV; Huang SH; Jang R; Zhao Y; Waterboer T; Hung RJ; Liu G
Int J Cancer; 2020 Apr; 146(8):2166-2174. PubMed ID: 31269236
[TBL] [Abstract][Full Text] [Related]
42. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
[TBL] [Abstract][Full Text] [Related]
43. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
[TBL] [Abstract][Full Text] [Related]
44. Identification of transcriptionally active HPV infection in formalin-fixed, paraffin-embedded biopsies of oropharyngeal carcinoma.
Morbini P; Alberizzi P; Tinelli C; Paglino C; Bertino G; Comoli P; Pedrazzoli P; Benazzo M
Hum Pathol; 2015 May; 46(5):681-9. PubMed ID: 25708613
[TBL] [Abstract][Full Text] [Related]
45. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
[TBL] [Abstract][Full Text] [Related]
46. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
47. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.
Jordan RC; Lingen MW; Perez-Ordonez B; He X; Pickard R; Koluder M; Jiang B; Wakely P; Xiao W; Gillison ML
Am J Surg Pathol; 2012 Jul; 36(7):945-54. PubMed ID: 22743284
[TBL] [Abstract][Full Text] [Related]
48. Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsil.
Xu T; Shen C; Wei Y; Hu C; Wang Y; Xiang J; Sun GH; Su F; Wang Q; Lu X
Cancer Med; 2020 Sep; 9(18):6556-6564. PubMed ID: 32717137
[TBL] [Abstract][Full Text] [Related]
49. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
[TBL] [Abstract][Full Text] [Related]
50. The role of high-risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases.
Laco J; Vosmikova H; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Nekvindova J; Vosmik M; Cermakova E; Ryska A
Virchows Arch; 2011 Feb; 458(2):179-87. PubMed ID: 21221634
[TBL] [Abstract][Full Text] [Related]
51. Threshold for interpretation of p16 immunostaining in fine-needle aspirate specimens of metastatic oropharyngeal squamous cell carcinoma.
Manucha V; Patel T; Grunes D; Akhtar I
J Am Soc Cytopathol; 2020; 9(3):177-184. PubMed ID: 32115376
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of p16 as a surrogate marker for transcriptionally active human papillomavirus status of oropharyngeal squamous cell carcinoma in an eastern Chinese population.
Xu S; Sun B; Zhou R; Shi C; Han Y; Li J; Sun J; Tian Z; Zhang Z; Li J
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):236-245.e2. PubMed ID: 31987673
[TBL] [Abstract][Full Text] [Related]
53. HPV-related Oropharyngeal Squamous Cell Carcinoma: p16INK4A Immunohistochemistry or HPV Genotyping?
Orsaria M; Marzinotto S; De Marchi L; Giacomarra V; Boria S; Rubini C; Londero AP; Di Loreto C; Mariuzzi L
Anticancer Res; 2015 Sep; 35(9):4733-9. PubMed ID: 26254363
[TBL] [Abstract][Full Text] [Related]
54. A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide.
Carlander AF; Jakobsen KK; Bendtsen SK; Garset-Zamani M; Lynggaard CD; Jensen JS; Grønhøj C; Buchwald CV
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372532
[TBL] [Abstract][Full Text] [Related]
55. Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial - A Trans-Tasman Radiation Oncology Group study.
Young RJ; Solomon B; Corry J; Angel C; Kenny L; Porceddu S; Wratten C; Macann A; Jackson JE; Herschtal A; Rischin D
Oral Oncol; 2020 Nov; 110():104988. PubMed ID: 32889172
[TBL] [Abstract][Full Text] [Related]
56. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
[TBL] [Abstract][Full Text] [Related]
57. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
Rooper LM; Gandhi M; Bishop JA; Westra WH
Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
[TBL] [Abstract][Full Text] [Related]
58. Comparison between p16 INK4A immunohistochemistry and human papillomavirus polymerase chain reaction assay in oral papillary squamous cell carcinoma.
Argyris PP; Kademani D; Pambuccian SE; Nguyen R; Tosios KI; Koutlas IG
J Oral Maxillofac Surg; 2013 Oct; 71(10):1676-82. PubMed ID: 23706276
[TBL] [Abstract][Full Text] [Related]
59. Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective.
Gelwan E; Malm IJ; Khararjian A; Fakhry C; Bishop JA; Westra WH
Am J Surg Pathol; 2017 Dec; 41(12):1722-1728. PubMed ID: 28877058
[TBL] [Abstract][Full Text] [Related]
60. Detection of HPV infection in head and neck squamous cell carcinoma: a practical proposal.
Dreyer JH; Hauck F; Oliveira-Silva M; Barros MH; Niedobitek G
Virchows Arch; 2013 Apr; 462(4):381-9. PubMed ID: 23503925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]